High incidence of nevirapine-associated rash in HIV-infected Chinese.
Ho
T T
TT
Wong
K H
KH
Chan
K C
KC
Lee
S S
SS
D019380:Anti-HIV Agents / Q000008:administration & dosage / Q000009:adverse effects; D018791:CD4 Lymphocyte Count; D002681:China / Q000208:ethnology; D016049:Didanosine / Q000008:administration & dosage; D003875:Drug Eruptions / Q000208:ethnology / Q000209:etiology*; D004359:Drug Therapy, Combination; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D019829:Nevirapine / Q000008:administration & dosage / Q000009:adverse effects*; D018894:Reverse Transcriptase Inhibitors / Q000008:administration & dosage / Q000009:adverse effects*; D018119:Stavudine / Q000008:administration & dosage; D015215:Zidovudine / Q000008:administration & dosage
D019380:Anti-HIV Agents; D018894:Reverse Transcriptase Inhibitors; D015215:Zidovudine; D019829:Nevirapine; D018119:Stavudine; D016049:Didanosine